Found Health Review 2026: Wide Formulary, Insurance Navigation, Hidden Fees
Found Health started as a prescription weight-management platform in 2020 and has grown to 300,000+ members on the strength of two real advantages: the widest drug formulary in GLP-1 telehealth and an insurance PA navigation system that works. Its main liability is operational — billing surprises and a buried cancellation fee that generate a consistent pattern of complaints across BBB, Trustpilot, and review aggregators.
This review covers what Found actually offers, at what price, and where the friction points are.
What makes Found different
Broadest formulary. Found prescribes Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Rybelsus, and — as of April 2026 — Foundayo (orforglipron). Foundayo is Eli Lilly's once-daily oral GLP-1 pill, a small molecule (not a peptide), which means it does not require the strict empty-stomach timing that oral Wegovy does. Found is one of the first telehealth platforms to list it. For patients seeking a needle-free option, this is a genuine differentiator.
Found also offers non-GLP-1 alternatives — metformin, bupropion-naltrexone (Contrave), topiramate — for patients who are ineligible for or intolerant of GLP-1s. No other major GLP-1 telehealth platform covers this range in one place.
Insurance PA support. For insured patients, Found's most consistent positive review theme is the prior-authorisation process. Found's team manages the documentation, submits to your insurer, and follows up. For commercial plans that cover Wegovy or Zepbound, this removes the most time-consuming part of access. The Insurance PLUS annual plan ($199/year) positions this specifically as a cost-effective service layer for insured patients.
The billing structure you need to understand
Found uses a dual-billing model that surprises a material portion of new members:
Bill 1 — Subscription/membership fee: $49/month (intro) to $199/month (self-pay PLUS). For insured patients on the annual plan: $199/year (~$17/month). This covers provider access, check-ins, insurance navigation, and the app.
Bill 2 — Medication cost: Billed separately by the pharmacy. With commercial insurance after PA approval: $0–$25/month with manufacturer savings cards. Without insurance: branded Wegovy runs approximately $349–499/month via NovoCare; branded Zepbound $299–449/month via LillyDirect. Found compounded semaglutide was listed at $189/month, but see the regulatory note below.
Best-case scenario for an insured patient: ~$17/month (annual plan) + ~$25/month drug copay = ~$42/month total. This is genuinely competitive — the most cost-effective insured path on the market if PA succeeds.
Worst case for a self-pay patient: $129/month subscription + $499/month branded Wegovy = ~$628/month. That is the top of the market.
The pattern in BBB complaints: patients who signed up expecting the subscription fee to cover the medication discovered the second bill at pharmacy pickup. The fee is disclosed in terms, but not prominently on the signup flow.
The cancellation fee
Found requires a 6-month commitment. If you cancel before the 6 months are up, there is a $99 cancellation fee. This is the single most-cited complaint across BBB (B- rating, ~48 complaints), Trustpilot (3.6/5), and review aggregators. Found's website does not present this prominently in the signup flow.
After the 6-month period, cancellation is month-to-month with no penalty. If you are considering Found, acknowledge the 6-month commitment explicitly before signing.
There is no money-back guarantee or weight-loss outcome guarantee.
Compounded GLP-1 — the legal caveat
Found had listed compounded semaglutide at approximately $189/month as a cash-pay entry point. This product line is legally precarious as of 2026.
The FDA declared the semaglutide shortage resolved on February 21, 2025. The §503A shortage-exemption compounding rights for semaglutide expired in the following months; large-scale 503B compounding was shut down by May 22, 2025. As of the April 30, 2026 FDA proposal, semaglutide will remain off the 503B bulk-substances list permanently.
Found operates as a technology platform, not a pharmacy — it is not itself a compounding provider. But the partner pharmacies filling compounded prescriptions from Found operate in the same constrained legal environment as every remaining 503A operator. The cheap cash-pay entry point via compounded semaglutide is not a reliable part of Found's value proposition for new patients in 2026.
For the full regulatory picture, see the compounding cliff timeline.
Clinical model
Found's visit model is asynchronous-first. Initial intake is a 10–15 minute health assessment (Found calls it MetabolicPrint™) followed by provider review within 1–2 days. Ongoing care runs through monthly check-ins for prescription refills, with unlimited secure messaging between visits.
The care team consists of board-certified prescribers (MDs and NPs) plus health coaches. Found's marketing references obesity medicine training, but it is not a specialist platform in the way Form Health (ABOM-certified physicians paired with RDNs) is. Found also deploys an AI companion called "Aimee" for 24/7 between-visit support.
Corporate structure note: Found Health, Inc. is a technology company. Clinical evaluations are performed by affiliated independent medical groups (Pippen Health, Cloud Health Medical Group, and others). Found explicitly states it "does not provide any medical services itself." This is an important disclosure — the prescriber you interact with is employed by an affiliated entity, not by Found directly.
Outcomes data: Found reports 12% average body weight lost in one year based on 1,773 members with self-reported weekly tracking. No independently published or peer-reviewed clinical trial data exists for Found's programme. Calibrate, by comparison, has published 19% at 36 months in clinical literature.
Who Found is right for
Best case — insured patient with employer coverage for Wegovy or Zepbound: The Insurance PLUS annual plan at $199/year plus ~$25/month drug copay is the most cost-effective route on this list. Found's PA navigation makes the coverage process active rather than passive.
Second-best case — patient who wants the widest formulary, including orforglipron: Found is currently the best platform for patients who want to explore Foundayo (orforglipron) — the needle-free once-daily oral GLP-1 approved April 2026 — or who may need a non-GLP-1 option if GLP-1s are not tolerated.
Not the right fit for:
- Cash-pay patients seeking the cheapest compounded option — Eden ($229/month) and Mochi ($178/month) are cheaper, with no 6-month commitment
- Patients who prioritise specialist-level clinical quality — Form Health's ABOM physician + RDN model is more rigorous
- Patients who need phone support or fast customer service response
- Medicare or Medicaid patients
Ratings summary
| Criteria | Score |
|---|---|
| Formulary breadth | ★★★★★ — broadest in category |
| Insurance PA support | ★★★★☆ — genuine strength, requires 2–4 weeks |
| Clinical quality | ★★★☆☆ — async, non-specialist |
| Pricing transparency | ★★☆☆☆ — dual billing causes frequent confusion |
| Customer service | ★★☆☆☆ — no phone; slow response times cited |
| Outcomes data | ★★☆☆☆ — self-reported only; 12% at 1 year |
For a full side-by-side comparison of all active GLP-1 telehealth platforms, see the provider comparison.
Frequently asked questions
Is Found Health a legitimate telehealth platform?
Yes. Found Health, Inc. is a venture-backed telehealth platform ($132M raised, Google Ventures-backed) that has been operating since 2020. It has a B- BBB rating with a moderate complaint volume. Found explicitly operates as a technology platform with clinical services provided by affiliated independent medical groups. It does not employ prescribers directly. It has not received an FDA warning letter as of May 2026.
What does Found Health cost per month?
There are two separate costs. The membership fee runs from $49/month (introductory) to $199/month for self-pay plans. For insured patients, an annual Insurance PLUS plan costs $199/year (~$17/month). Medication is billed separately — with insurance, GLP-1 copays are typically $0–$25/month; without insurance, cash-pay branded GLP-1s run $350–700/month. This dual-billing structure is the most common source of billing-surprise complaints.
Does Found Health offer orforglipron (Foundayo)?
Yes. Found is one of the first telehealth platforms to list Foundayo (orforglipron, Eli Lilly's oral GLP-1 small molecule) as a prescribable option following its FDA approval on April 8, 2026. Orforglipron is a once-daily pill that does not require a specific meal or fasting window, unlike oral semaglutide. This is a genuine first-mover advantage for patients seeking a needle-free GLP-1 option.
Does Found Health accept insurance?
Yes. Found accepts major commercial insurance including Aetna, Cigna, and Blue Cross Blue Shield. It does not accept Medicare or Medicaid. For insured patients, Found's PA support navigates the prior-authorisation process for Wegovy or Zepbound. The Insurance PLUS annual plan ($199/year) is specifically designed for insured patients.
What is Found Health's cancellation fee?
Found charges a $99 fee if you cancel before completing a 6-month commitment period. This fee is not prominently disclosed on the website before sign-up and is the most common complaint in BBB filings. After the 6-month period, cancellation is month-to-month with no penalty. There is no money-back guarantee.
Is Found Health associated with Mayo Clinic?
No. Found Health has no investment, partnership, or endorsement from Mayo Clinic. Mayo Clinic launched a separate GLP-1 telehealth program in January 2024 in partnership with Amwell Medical Group (called the Mayo Clinic Diet Medical Weight Loss Rx) — this is a competing independent product that was sometimes confused with Found in early coverage.